Shell Asset Management’s CONMED CNMD Stock Holding History

Shell Asset Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,294	Closed	-$691K	–	1517
2021 Q1	$691K	Sell	5,294 -30	-0.6%	-$3.61K	0.01%	698
2020 Q4	$596K	Sell	5,324 -2,297	-30%	-$217K	0.01%	722
2020 Q3	$600K	Hold	7,621	–	–	0.01%	598
2020 Q2	$549K	Sell	7,621 -67	-0.9%	-$4.66K	0.01%	618
2020 Q1	$440K	Sell	7,688 -117	-1%	-$10.8K	0.01%	717
2019 Q4	$873K	Sell	7,805 -155	-2%	-$16.5K	0.02%	602
2019 Q3	$765K	Sell	7,960 -68	-0.8%	-$6.38K	0.02%	663
2019 Q2	$687K	Sell	8,028 -183	-2%	-$15K	0.02%	747
2019 Q1	$683K	Buy	+8,211	New	+$597K	0.02%	763
2014 Q3	–	Sell	-42,512	Closed	-$1.69M	–	863
2014 Q2	$1.88M	Sell	42,512 -494	-1%	-$22.4K	0.03%	519
2014 Q1	$1.87M	Buy	+43,006	New	+$1.92M	0.03%	526

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Shell Asset Management's CNMD Position: Q2 2021 in Review

Shell Asset Management sold out of CONMED (CNMD) in Q2 2021, closing a stake of 5,294 shares — an estimated $691K sold.

Shell Asset Management first reported a position in CNMD in Q1 2014 and held it in 11 quarters. The position peaked at $1.88M in Q2 2014. 252 funds tracked by Wall St. Rank hold CNMD as of Q2 2021.

Shell Asset Management reported no remaining CONMED position as of Q2 2021 after selling out during the quarter.
Shell Asset Management sold 5,294 CONMED shares in Q2 2021, an estimated $691K.
Shell Asset Management first reported a position in CONMED in Q1 2014 and held it in 11 quarters.
Shell Asset Management's CONMED position peaked at $1.88M in Q2 2014.
252 funds tracked by Wall St. Rank held CONMED as of Q2 2021.

Based on Shell Asset Management's 13F filing for Q2 2021, filed 12 Aug 2021.